AstraZeneca Spinout Venture Part 2
| Reference number | |
| Coordinator | AstraZeneca AB - AstraZeneca AB, Södertälje |
| Funding from Vinnova | SEK 5 570 687 |
| Project duration | January 2017 - December 2019 |
| Status | Completed |
Important results from the project
The Spinn-Out project part two intended to pilot 1 or 2 projects based on the business principles derived from part one of the project. The aim was to identify a mechanism for the release of shelved innovation from large corporations.
Expected long term effects
A series of tentative projects were evaluated and reformatted to suit SME perspectives and the project chosen as the pilot resulted in the formation and capitalization of OnDosis AB.
Approach and implementation
** Denna text är maskinöversatt ** In part two of the project,potential projects were evaluated, in total nine different projevcts were assessed regarding - Innovation - Marketing potential - Intellectual property - Potential conflict of interest - Development costs, existing and future - Competence Requirements for the further development of the projektet - Interest from 6 different VC companies I cooperation with investors business plans were prepared as well as the recruitment of the CEO and key personnel.